Role of islet cell antibodies in the pathogenesis of type I diabetes.
D000818:Animals; D000906:Antibodies / Q000032:analysis / Q000502:physiology*; D000917:Antibody Formation; D000954:Antigens, Surface / Q000276:immunology; D001323:Autoantibodies / Q000032:analysis / Q000096:biosynthesis / Q000502:physiology*; D001324:Autoantigens / Q000276:immunology; D001666:Binding Sites, Antibody; D003602:Cytotoxicity, Immunologic; D003922:Diabetes Mellitus, Type 1 / Q000209:etiology / Q000276:immunology*; D004797:Enzyme-Linked Immunosorbent Assay; D005455:Fluorescent Antibody Technique; D006801:Humans; D007515:Islets of Langerhans / Q000276:immunology*; D051379:Mice; D011869:Radioligand Assay; D051381:Rats; D013205:Staphylococcal Protein A / Q000378:metabolism
D000906:Antibodies; D000954:Antigens, Surface; D001323:Autoantibodies; D001324:Autoantigens; D013205:Staphylococcal Protein A; C024211:islet cell antibody